3Bar Biologics, Inc. — Form D/A
3Bar Biologics, Inc. of COLUMBUS, OH, a company, filed a Form D amendment with the SEC on 2017-04-17. The offering totals $2.0M, of which $1.6M was reported sold. Industry: Other Technology.
Offering
- Filed: 2017-04-17
- Form: D/A
- Accession: 0001693990-17-000002
- Industry: Other Technology
- Exemptions: 06b
- Total offering: $2.0M
- Amount sold: $1.6M
- Remaining: $425K
- Minimum investment: $10K
- Investors: 12
- Date of first sale: 2016-12-30
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-278601
Issuer
- Name: 3Bar Biologics, Inc.
- CIK: 0001693990
- Entity type: Corporation
- Jurisdiction: OHIO
- Incorporated: 2013
- Address: 1275 KINNEAR ROAD, COLUMBUS, OH, 43212
- Phone: 614-271-9388
Officers, directors & promoters (5)
| Name | Role | Location |
|---|
| David Bergeron | Director | Niwot, CO |
| Richard Maksimoski | Director | Columbus, OH |
| Bruce Caldwell | Director | Columbus, OH |
| Bruce Caldwell | Executive Officer | Columbus, OH |
| Rashmi Agnihotri | Director | Columbus, OH |
Other filings by this issuer (2)
More